Skip to main content
. Author manuscript; available in PMC: 2018 Apr 30.
Published in final edited form as: Int J Tuberc Lung Dis. 2015 Sep;19(9):1115–xv. doi: 10.5588/ijtld.15.0158

Figure 1. Percentage Reductions in Overall and MDR TB Incidence and Prevalence.

Figure 1

All strategies considered reduce future TB prevalence and incidence over the 10-year analysis period relative to no intervention, although MDR TB prevalence grows in absolute size in all cases. PPM with GeneXpert for all diagnosis produces the largest percentage decreases in TB incidence and prevalence relative to the status quo, and GeneXpert for DST has the smallest effect on the overall TB as it intentionally targets MDR which affects a relatively small number of TB cases. GX = GeneXpert.